Resultados de búsqueda - Michele Sisani
- Mostrando 1 - 2 Resultados de 2
-
1
Results of the observational prospective RealFLOT study por Elisa Giommoni, Daniele Lavacchi, Giuseppe Tirino, Lorenzo Fornaro, Francesco Iachetta, Carmelo Pozzo, Maria Antonietta Satolli, Andrea Spallanzani, Marco Puzzoni, Silvia Stragliotto, Michele Sisani, Vincenzo Formica, Filippo Giovanardi, Antonia Strippoli, Michele Prisciandaro, Samantha Di Donato, Luca Pompella, Irene Pecora, Alessandra Romagnani, Sara Fancelli, Marco Brugia, Serena Pillozzi, Ferdinando De Vita, Lorenzo Antonuzzo
Publicado 2021Artigo -
2
Sunitinib administered on 2/1 schedule in patients with metastatic renal cell carcinoma: the RAINBOW analysis por Sergio Bracarda, Roberto Iacovelli, Luca Boni, Mimma Rizzo, Lisa Derosa, Marta Rossi, Luca Galli, Giuseppe Procopio, Michele Sisani, Flavia Longo, Matteo Santoni, Franco Morelli, Giuseppe Di Lorenzo, Amelia Altavilla, Camillo Porta, Andrea Camerini, Bernard Escudier, Angelo Martignetti, Riccardo Ricotta, Donatello Gasparro, Roberto Sabbatini, Giovanni Luca Ceresoli, Alessandra Mosca, Daniele Santini, Claudia Caserta, Luigi Cavanna, Francesco Massari, Teodoro Sava, C. Boni, Elena Verzoni, Giacomo Cartenì, Alketa Hamzaj
Publicado 2015Artigo
Herramientas de búsqueda:
Materias Relacionadas
Adverse effect
Internal medicine
Medicine
Oncology
Cancer
Chemotherapy
Clinical endpoint
Clinical trial
Colorectal cancer
Docetaxel
Environmental health
Febrile neutropenia
Incidence (geometry)
Neutropenia
Optics
Oxaliplatin
Perioperative
Physics
Population
Renal cell carcinoma
Sunitinib
Surgery
Surgical oncology
Tolerability
Toxicity